Advanced search
Publication Cover
Expert Review of Clinical Pharmacology Volume 12, 2019 - Issue 8
Submit an article Journal homepage
1,948
Views
7
CrossRef citations to date
0
Altmetric
Editorial

Should endotoxin be a research priority in Gram-negative sepsis and septic shock?

Jihad MallatDepartment of Critical Care Medicine, Cleveland Clinic Abu Dhabi, Abu Dhabi, UAEORCID Iconhttps://orcid.org/0000-0001-6372-7360View further author information
ORCID Icon,
Sebastiano LeoneDivision of Infectious Diseases, “San Giuseppe Moscati” Hospital, Avellino, ItalyCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0001-7852-4101View further author information
ORCID Icon,
Marco CascellaDivision of Anesthesia and Pain Medicine, Istituto Nazionale Tumori, IRCCS Fondazione G. Pascale, Naples, ItalyORCID Iconhttps://orcid.org/0000-0002-5236-3132View further author information
ORCID Icon &
Marco FioreDepartment of Women, Child and General and Specialized Surgery, University of Campania “Luigi Vanvitelli”, Naples, ItalyORCID Iconhttps://orcid.org/0000-0001-7263-0229View further author information
ORCID Icon
Pages 697-699 | Received 24 Mar 2019, Accepted 03 Jun 2019, Published online: 13 Jun 2019

References

  • Beutler B. Inferences, questions and possibilities in toll-like receptor signaling. Nature. 2004;430:257–263.
  • Cristofaro P, Opal SM. Role of toll-like receptors in infection and immunity: clinical implications. Drugs. 2006;66:15–29.
  • Marshall JC. Endotoxin in the pathogenesis of sepsis. Contrib Nephrol. 2010;167:1–13.
  • Cohen J. The detection and interpretation of endotoxaemia. Intensive Care Med. 2000;26:51–56.
  • Suffredini AF, Fromm RE, Parker MM, et al. The cardiovascular response of normal humans to the administration of endotoxin. N Engl J Med. 1989;321:280–287.
  • Bottiroli M, Monti G, Pinciroli R, et al. Prevalence and clinical significance of early high endotoxin activity in septic shock: an observational study. J Crit Care. 2017;41:124–129.
  • Cruz DN, Antonelli M, Fumagalli R, et al. Early use of polymyxin B hemoperfusion in abdominal septic shock: the EUPHAS randomized controlled trial. Jama. 2009;301:2445–2452.
  • Cutuli SL, Artigas A, Fumagalli R, et al. Polymyxin-B hemoperfusion in septic patients: analysis of a multicenter registry. Ann Intensive Care. 2016;6:77.
  • Lee CT, Tu YK, Yeh YC, et al. Effects of polymyxin B hemoperfusion on hemodynamics and prognosis in septic shock patients. J Crit Care. 2018;43:202–206.
  • Chang T, Tu YK, Lee CT, et al. Effects of Polymyxin B hemoperfusion on mortality in patients with severe sepsis and septic shock: a systemic review, meta-analysis update, and disease severity subgroup meta-analysis. Crit Care Med. 2017;45:858–864.
  • Payen DM, Guilhot J, Launey Y, et al. Early use of polymyxin B hemoperfusion in patients with septic shock due to peritonitis: a multicenter randomized control trial. Intensive Care Med. 2015;41:975–984.
  • Dellinger RP, Bagshaw SM, Antonelli M, et al. Effect of targeted Polymyxin B hemoperfusion on 28-day mortality in patients with septic shock and elevated endotoxin level: the EUPHRATES randomized clinical trial. Jama. 2018;320:1455–1463.
  • Klein DJ, Foster D, Walker PM, et al. Polymyxin B hemoperfusion in endotoxemic septic shock patients without extreme endotoxemia: a post hoc analysis of the EUPHRATES trial. Intensive Care Med. 2018;44:2205–2212.
  • Singer M, Deutschman CS, Seymour CW, et al. Third international consensus definitions for sepsis and septic shock (Sepsis-3). Jama. 2016;315:801–810.
  • Rhodes A, Evans LE, Alhazzani W, et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock: 2016. Intensive Care Med. 2017;43:304–377.
  • Leone S, Damiani G, Pezone I, et al. New antimicrobial options for the management of complicated intra-abdominal infections. Eur J Clin Microbiol Infect Dis. 2019;38:819–827.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.